Table 5. Clinical characteristics after remdesivir course completion (N = 88).

HF: heart failure; ALT: alanine transaminase; AST: aspartate aminotransferase; SrCr: serum creatinine; N: total participants

Variable	Level	N	%
History of hypertension	Yes	55	62.5
	No	33	37.5
Dyslipidemia	Yes	17	19.3
	No	71	80.7
Hypothyroidism	Yes	1	1.1
	No	87	98.9
Kidney dysfunction	Yes	6	6.8
	No	82	93.2
HF	Yes	10	11.4
	No	78	88.6
Diabetes mellitus	Yes	43	48.9
	No	45	51.1
SrCr (mmol/L) increase	Yes	47	53.4
	No	41	46.6
Hemoglobin decrease	Yes	49	55.7
	No	39	44.3
Glucose increase	Yes	49	55.7
	No	39	44.3
ALT increase	Yes	48	54.5
	No	40	45.5
AST increase	Yes	40	45.5
	No	48	54.5